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ABSTRACT
In this study we examined the cytotoxic effect of ZnO nanoparticles on various human cancer and normal 
cells. We found that the ZnO nanoparticles exerted a cytotoxic effect on the human glioma cell lines A172, U87, 
LNZ308, LN18, and LN229, whereas no cytotoxic effect was observed on normal human astrocytes. Similarly, 
the ZnO nanoparticles induced cell death in breast and prostate cancer cell lines while no major effect was 
observed in the respective normal breast and prostate cell lines. Using the fl uorescent dye 2,7-dichlorofl uorescein 
diacetate, we found that treatment of the glioma cells with ZnO nanoparticles induced a large increase in the 
generation of reactive oxygen species (ROS) and treatment of the cells with N-acetyl cysteine decreased the 
cytotoxic effect of the ZnO nanoparticles. In contrast, a smaller effect on ROS generation was observed in the 
normal astrocytes. These results suggest that ZnO nanoparticles may be employed as a selective cytotoxic agent 
for the eradication of cancer cells.
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Introduction
Nanoparticles are making signifi cant contributions to 
the development of new approaches of drug delivery 
in cancer and can provide a platform for combined 
therapeutics with subsequent monitoring of response 
[1, 2]. Progress in utilizing inorganic nanoparticles for 
biomedical applications has advanced rapidly due to 
the extensive amount of work done in the synthesis 
and modification of these particles [1]. Among 
inorganic materials, metal oxide nanoparticles are 
of special interest. Zinc oxide (ZnO) belongs to a 
group of metal oxides, which is characterized by 
photocatalytic ability, and photo-oxidizing capacity 
against chemical and biological species [2]. Moreover, 
ZnO utilizes a multifunctional nanoplatform that 
bombards malignant cells from the outside, through 
the external release of reactive oxygen species (ROS) 
[3].  However, the anti-cancer properties of zinc oxide 
(ZnO) nanoparticles remain an undeveloped area 
which is of potential medical interest. In the present 
study we investigated the cytotoxic effect of these 
nanoparticles against glioma and other tumor cells. 
Gliomas are the most frequent primary brain 
tumors, accounting for > 50% of all brain tumors 
[4]. Glioblastomas, the most malignant form, are 
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characterized by increased proliferation and invasion 
into the surrounding normal brain tissue [5]. Current 
treatment options include surgery, radiation therapy, 
and chemotherapy. However, these tumors are 
resistant to the different forms of chemotherapy 
and radiotherapy, which impacts patient survival. 
Indeed, the prognosis of patients with glioblastomas 
remains extremely poor, and the median survival 
of 12 months from the time of diagnosis has not 
significantly changed during the last few years [6]. 
Therefore, the search for novel and more effective 
chemotherapeutic agents against glioma cells is of 
utmost importance.
In this study we generated ZnO nanoparticles via 
ultrasound irradiation, which has been described as 
an effective technique for the synthesis of nanophase 
materials [7]. The effect of ZnO (60 nm) nanoparticles 
was examined on the human glioma cell lines U87, 
A172, U251, LNZ308, LN18, LN229, and on human 
normal astrocytes as well as on  breast and prostate 
cancer cells and their respective normal cell lines. 
1. Results and discussion 
1.1 Particle characterization
The zinc oxide nanoparticles were formed using 
sonchemical irradiation according to the following 
reactions:
1) Zn(OAc)2(s)  Zn
2+
(aq) + 2OAc (aq)  
2) Zn2+(aq) + 2OH (aq)  Zn(OH)2(s) 
  ZnO(s) + H2O
The sonochemical irradiation of a 
liquid causes two primary effects, 
namely, cavitation (bubble formation, 
growth, and collapse), and heating. 
When the microscopic cavitation 
bubbles collapse near the surface 
of  the  substrate ,  they generate 
powerful shock waves and microjets 
that cause effective stirring/mixing 
of the disturbed layer of liquid. 
The after effects of the cavitation 
are several hundred times greater 
in heterogeneous systems than in 
homogeneous systems [8]. In our case, 
the ultrasonic waves promote the fast production of 
the newly-formed zinc oxide (ZnO) nanoparticles. 
The X-ray diffraction (XRD) patterns (Fig. 1) of 
sonochemically-synthesized ZnO nanoparticles 
demonstrate that the zinc oxide is crystalline in nature, 
and the diffraction peaks match very well a hexagonal 
phase of ZnO (PDF: 89-7102). The peaks at 2θ = 31.77o, 
34.42o, 36.25o, 47.54o, 56.6o, 62.85o, and 67.95o are 
assigned to the (100), (002), (101), (102), (110), (103), 
and (112) refl ection lines of hexagonal ZnO particles, 
respectively. No characteristic peaks of any impurities 
were detected. The particle size estimated by the 
Debye–Scherrer (DS) equation is 60 nm.
The shape and size of the above-mentioned 
product was determined by transmission electron 
microscopy (TEM) measurements as shown in Fig. 2. 
The TEM images of the as-prepared nanoparticles 
show isolated particles with an average diameter of 
60 nm ± 1 nm for the ZnO, as well as a network of 
connected particles.
1.2 ZnO nanoparticles exert a dose-dependent 
cytotoxic effect on glioma cells
To examine the  cytotoxic  effect  of  the  ZnO 
nanoparticles we first employed the A172, U87, 
and LNZ308 glioma cell lines and normal human 
astrocytes. The cells were treated with different 
concentrations of the ZnO nanoparticles (1.5 
Figure 1 X-ray diffraction pattern of as-prepared ZnO nanoparticles. The XRD patterns 
demonstrate the crystalline nature of zinc oxide. The peaks in order of increasing 2θ 
are assigned to the (100), (002), (101), (102), (110), (103), and (112) reflection lines of 
hexagonal ZnO particles. No characteristic peaks of any impurities were detected. The 
particle size estimated by the Debye–Scherrer (DS) equation is 60 nm
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death only in the MCF-7 cancer cells, 
whereas no significant changes were 
observed in the viability of the MCF-
10A normal cells. Similar results 
were obtained with the prostate cells. 
Thus, treatment of the prostate cancer 
cell line PC-3 with 10 mmol/L ZnO 
nanoparticles induced a large cytotoxic 
effect in these cells (Fig. 4(b)), whereas 
no cell death was observed in the 
normal RWPE-1 prostate cells.
Figure 2 Transmission electron micrograph of the as-prepared zinc oxide nanoparticles, 
showing isolated particles with an average diameter of 60 nm ± 1 nm, as well as a network 
of connected particles
and 10 mmol/L) and the cytotoxic effect 
of the nanoparticles was determined using 
the measurement of lactate dehydrogenase 
(LDH) release into the culture supernatant. As 
presented in Fig. 3(a), some cytotoxic effect 
was already observed at 1 and 5 mmol/L ZnO 
nanoparticles whereas maximal effect was 
obtained at a concentration of 10 mmol/L 
nanoparticles. Similar effects were obtained 
in the two additional glioma cell lines, LN18 
and LN229, treated with 10 mmol/L ZnO 
nanoparticles (Fig. 3(b)). In contrast, no 
significant cytotoxic effect was observed 
in the normal human astrocytes at  the 
highest concentration (10 mmol/L) of the 
nanoparticles that significantly effected the 
cancer cells (Fig. 3(c)), suggesting that the 
effect of the ZnO nanoparticles was selective 
for the glioma cell lines.
 
1.3 Selective cytotoxic effect of ZnO 
nanoparticles on breast and prostate cancer 
cells
We further examined the selective cytotoxic 
effect of the ZnO nanoparticles in breast and 
prostate cancer cells. In these studies we 
employed the breast cancer cell line MCF-7 
cancer cells and the normal breast cell line 
MCF-10A. Both cell lines were treated with 10 
mmol/L ZnO nanoparticles and LDH assay 
was performed 24 h thereafter. As shown in 
Fig. 4(a), the ZnO nanoparticles induced cell 
Figure 3 Cytotoxic effect of ZnO nanoparticles in glioma cell lines. The glioma 
cell lines A172, U87, and LNZ308 were treated with different concentrations of 
ZnO nanoparticles (1 mmol/L, 5 mmol/L, and 10 mmol/L) for 24 h (a). The glioma 
cell lines LN18, LN229, and normal human astrocytes (b) were treated with 10 
mmol/L nanoparticles for 24 h and 72 h. The cytotoxicity of the nanoparticles 
was determined using LDH analysis in the culture supernatants and is expressed 
in terms of the optical density (OD) at 490 nm. The results are the means ± SD 
from three independent experiments *p < 0.0001
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1.4 ZnO nanoparticles induce cell 
apoptosis in glioma cells
To investigate whether the cytotoxic 
effect of the ZnO nanoparticles is 
associated with the induction of cell 
apoptosis we treated the U87 and 
LNZ308 glioma cells with 1, 5, and 
10 mmol/L ZnO nanoparticles for 24 
and 72 h and analyzed cell apoptosis 
by propidium iodide staining and 
fluorescence-activated cell sorting 
(FACS) analysis. ZnO nanoparticles 
induced only a minor increase in cell 
apoptosis after 24 h of treatment (data 
not shown), whereas significant cell 
apoptosis was observed after 72 h 
of treatment in all the cell lines that 
were examined (Fig. 5(a)). In contrast, 
and similar to the results of the LDH 
analysis, no signifi cant cell apoptosis 
was observed in the normal human 
astrocytes after treatment for either 
24 or 72 h with 10 mmol/L ZnO 
nanoparticles (Fig. 5(b)).
1.5 ZnO nanoparticles induce 
generation of ROS in glioma cells
To delineate the mechanisms involved 
in the cytotoxic effect of the ZnO 
nanoparticles we examined the effect 
Figure 4 Cytotoxic effect of ZnO nanoparticles in breast cancer and normal cells, and prostate cancer and normal cells. The breast cancer cells 
MCF-7 (a), the normal breast cells MCF10A, the prostate cancer cells PC-3 (b) and the normal prostate cells, RWPE-1 were treated with 
10 mmol/L ZnO nanoparticles for 24 h. The cytotoxicity of the nanoparticles was determined using LDH analysis in the culture supernatants and 
expressed in terms of the optical density (OD) at 490 nm. The results are the means ± SD from three independent experiments *p < 0.0001
Figure 5 ZnO nanoparticles induce cell apoptosis in glioma cells. The U87 and LNZ308 
glioma cells (a) were treated with 1 mmol/L, 5 mmol/L, and 10 mmol/L ZnO nanoparticles 
for 72 h and normal human astrocytes (b) were treated with 10 mmol/L ZnO nanoparticles 
for 24 h and 72 h. Cell apoptosis was determined using propidium iodide staining and FACS 
analysis. The results are the means ± SD from three independent experiments *p < 0.005, 
**p < 0.05, ***p < 0.01
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of these nanoparticles on the generation of ROS in the 
glioma cells and normal human astrocytes. U87 cells 
or normal astrocytes were treated with 10 mmmol/L
ZnO nanoparticles for 24 h and the generation of 
ROS was examined using 2,7-dichlorofluorescein 
diacetate (DCFH-DA), a specific fluorescent probe 
commonly used for the detection of intracellular 
ROS [9]. DCFH-DA is cell permeable, and, after 
uptake, it is cleaved by intracellular esterases to 
2,7-dichlorofluorescin (DCFH), which is trapped 
within the cells, and is oxidized to the fluorescent 
molecule 2,7-dichlorofl uorescein (DCF) by ROS. This 
highly fluorescent derivative is readily detectable 
using flow cytometry. We found an increase in the 
fluorescence intensity of DCF after 24 h exposure 
to 10 mmmol/L ZnO nanoparticles in the U87 cells 
(Fig. 6(a)). As a positive control in these experiments 
we used hydrogen peroxide H2O2 [10]. In contrast, 
the ZnO nanoparticles induced a smaller increase 
in the fluorescence intensity of DCF in the normal 
astrocytes cells as compared to H2O2 (Fig. 6(b)).
1.6 Role of ROS in the cytotoxic effect of the ZnO 
nanoparticles
To determine the role of ROS in the cytotoxic effect 
of the ZnO nanoparticles, we employed the ROS 
Figure 6 Generation of ROS in glioma and normal cells treated with ZnO nanoparticles. The generation of 
ROS was determined in U87 cells (a) or astrocytes (b) treated with 10 mmol/L ZnO nanoparticles for 24 h using 
the oxidation sensitive dye DCFH-DA and FACS analysis. Representative histograms of ROS production in U87 
glioma cells or astrocyte normal cells are compared to H2O2 as a positive control
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quencher, N-acetyl cysteine (NAC) [11]. U87 cells 
were treated with 10 mmol/L NAC prior to their 
treatment with the ZnO nanoparticles and cell 
apoptosis was determined after 24 h. As shown in 
Fig. 7, treatment of the U87 cells with 10 mmol/L 
ZnO for 24 h resulted in around 10% apoptotic cells. 
The effect of the ZnO nanoparticles was completely 
absent in cells pre-treated with NAC, suggesting 
that generation of ROS by the ZnO nanoparticles 
mediated their apoptotic effect.
Recent  developments  in  cancer  research 
suggest that a number of apoptotic stimuli share 
common mechanistic pathways characterized by 
the generation of ROS through oxidative stress [12]. 
ROS typically include the superoxide radical (O2 ), 
hydrogen peroxide (H2O2), and the hydroxyl radical 
(·OH) which cause damage to cellular components 
such as lipids, DNA, and proteins and eventually 
leads to cell death [13]. In agreement with previous 
reports, we found that the ZnO nanoparticles 
induced the generation of ROS in the glioma cells, 
whereas normal astrocytes exhibited lower levels of 
ROS in response to the ZnO nanoparticles. Moreover, 
our results using NAC demonstrated that the 
ROS contributed to the apoptotic effect of the ZnO 
nanoparticles.
Our results suggest that the basis for the selective 
effect of the ZnO nanoparticles on cancer cells may 
be due to the increased generation of ROS and to an 
increased sensitivity of these cells to oxidative stress. 
Indeed, it has been shown that leukemia and ovarian 
cancer cells are more sensitive to different agents that 
generate ROS such as 2-methoxyestradiol [14]. It is 
worth mentioning that the toxicity on the cancer cells 
is a result of the exposure to the ZnO nanoparticles 
alone, and not a result of photoexposure of the ZnO 
nanoparticles.  
2. Conclusion
In this study, we investigated the cytotoxic effects 
of 60-nm ZnO nanoparticles, synthesized by the 
sonochemical technique, on normal and tumor 
cells focusing on glioma cells. The effect of the 
ZnO nanoparticles on cell death and apoptosis was 
characterized and the role of ROS in the cytotoxic 
effect of these nanoparticles was determined. 
In contrast to their cytotoxic effect on the different 
glioma cells, the ZnO nanoparticles did not exert any 
cytotoxic effect, even at a concentration of 10 mmol/L,
on normal human astrocytes. Similarly, the ZnO 
nanoparticles induced cell death in breast and 
prostate cancer cells but did not affect the viability of 
normal breast and prostate cells. Collectively, these 
results demonstrate that the ZnO nanoparticles exert 
selective cytotoxic effect on cancer cells. The ROS 
generated in response to treatment with the ZnO 
Figure 7 Quenching of ROS by N-acetyl cysteine (NAC) protects U87 cells from ZnO 
nanoparticle-induced apoptosis. U87 cells were pre-treated with 10 mmol/L NAC prior to 
treatment with 10 mmol/L ZnO nanoparticles for an additional 24 h. Cell apoptosis was 
determined using propidium iodide staining and FACS analysis. The results show signifi cant 
differences in cell death (%) between treated and non-treated cells *p < 0.0001
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nanoparticles in the cancer cells is larger compared to 
that generated in the normal cells and together with 
the increased sensitivity of the cancer cells, result 
in selective cell death of these cells. The results of 
this study suggest that ZnO nanoparticles should be 




The synthesis of zinc oxide nanoparticles (ZnO) with 
particle size of 60 nm was carried out as previously 
described [15]. Briefly, 2.5 g of zinc (II) acetate 
dihydrate (Aldrich 98+%) was dissolved in 100 mL 
of 10% (v/v) water–N,N-dimethylformamide (DMF; 
Aldrich 99.8%) and irradiated with a high intensity 
ultrasonic horn (Ti-horn, 20 kHz, 100 W/cm2) under 
a flow of argon at room temperature for 3 h. The 
product obtained was washed thoroughly with 
doubly distilled water and finally with absolute 
ethanol and dried in vacuum. 
Zinc oxide was first dispersed in phosphate 
buffered saline (PBS), then sonicated in a sonication 
bath to avoid aggregates ,  and used at  f inal 
concentrations of 1, 3, 5, 8, and 10 mmol/L in culture 
media for 24 and 48 h. Control wells contained 
cells with supplemented media (2 mL) without 
nanoparticles.
The XRD measurements were carried out with a 
Bruker D8 diffractometer. To prepare an XRD sample, 
an ethanol suspension containing the metal oxide 
particles was deposited drop-wise on a single crystal 
silicon substrate and dried to obtain a thin layer of 
the particles. The transmission electron micrographs 
(TEM) were obtained by employing a JEOL-JEM 
100SX microscope. Samples for the TEM examination 
were prepared by suspending dried samples in 
absolute ethanol. A drop of the sample suspension 
was allowed to dry on a copper grid (400 mesh, 
Electron Microscopy Sciences) coated with a carbon 
film. Since the particles are heavily aggregated, the 
small separated particles detected in the TEM serve 
as our measure of the particle sizes. 
3.2 Cell lines
The glioma cell lines A172, U87, LN18, and LN229 
were obtained from American Type Culture 
Collection (Manassas, VA), and the LNZ308 cells were 
obtained from Oliver Bogler (M. D. Anderson Cancer 
Center). Cells were grown on tissue culture dishes 
at a concentration of 2 × 105 cells/mL in Dulbecco’s 
modified Eagle medium DMEM (Sigma) containing 
10% heat-inactivated fetal calf serum (FCS), 2 mmol/L 
glutamine, penicillin (50 units/mL), and streptomycin 
(0.05 mg/mL). The medium was changed every 3 to 
4 days and cultures were split using 0.25% trypsin. 
Normal astrocytes were obtained from Cambrex 
(Walkersville, MD). Cells were grown in an astrocyte-
specific medium provided by Cambrex. Equal 
numbers of cells (2 × 105 cells/mL) were plated for all 
the experiments.
Breast cancer cells, MCF-7, breast normal cells 
MCF-10A [16], and prostate normal cells RWPE-1 
were obtained from ATCC. The MCF-10A cells 
were grown in mammary epithelial basal medium 
(MEBM) supplied with bovine pituitary extract 
(BPE) 13 mg/mL, 2 mL; hydrocortisone 0.5 mg/mL, 
0.5 mL; human epidermal growth factor (hEGF) 
10 μg/mL, 0.5 mL; insulin 5 mg/mL, 0.5 mL), at 
37.0 °C. The MCF-7 human breast tumor cells were 
maintained in Eagle’s minimal essential medium 
(EMEM) containing 0.01 mg/mL bovine insulin; fetal 
bovine serum to a fi nal concentration of 10%, in air 
95%/carbon dioxide (CO2) 5%, at 37.0 °C.
The RWPE-1 normal cells [17] were grown in 
a base medium, keratinocyte serum-free medium 
(K-SFM), provided by Gibco. To make the complete 
growth medium, we added the following components 
to the base medium: 0.05 mg/mL BPE, 5 μg/mL EGF 
in air 95%/carbon dioxide (CO2) 5% at 37.0 °C.
3.3 Measurements of cell apoptosis
Cell apoptosis [18] was measured using propidium 
iodide staining and analysis by flow cytometry 
[19]. The cells were scraped and centrifuged with 
the supernatant medium at 3500 rpm for 5 min. 
Following washes, cells were resuspended in PBS 
and fixed in 70% ethanol for 1 h on ice. Fixed cells 
were washed with PBS and stained with propidium 
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iodide (5 μg/mL) solution containing ribonuclease 
(RNase) (50 μmol/L). Cells were then analyzed on a 
Becton Dickinson FACSCalibur fl ow cytometer. The 
sub-G0 population of the cells was determined.
3.4 LDH measurement
LDH levels  were determined in the culture 
supernatants using a commercial LDH Kit (Pointe 
Scientific, Inc., Lincoln Park, MI, USA). This is a 
colorimetric assay that quantitatively measures LDH, 
a stable cytosolic enzyme that is released upon cell 
lysis. Released LDH in culture supernatants was 
measured with a 30-min coupled enzymatic assay 
that results in the conversion of a tetrazolium salt 
(INT) into a red formazan product. The amount of 
color formed is proportional to the number of lysed 
cells [20]. 100 μL of cell medium was used for LDH 
analysis. Absorbance at 490 nm was measured with 
a standard microplate reader (Victor3 multilabel 
counter, PerkinElmer, Boston, MA). Each experiment 
was done in triplicate.
3.5 Intracellular ROS measurement 
The production of intracellular ROS was measured 
using DCFH-DA [21]. DCFH-DA passively enters 
the cell where it reacts with ROS to form the highly 
fluorescent compound DCF. Briefly, 10 mmol/L 
DCFH-DA stock solution (in methanol) was diluted 
500-fold in DMEM medium without phenol red to 
yield a 20 μmol/L working solution. After 24 h of 
exposure to ZnO nanoparticles, the cells in the 6-well 
plate were washed twice with the medium and then 
incubated in 2 mL working solution of DCFH-DA at 
37 °C for 30 min. Fluorescence was then determined 
at 485-nm excitation and 520-nm emission using a 
microplate reader.
3.6 ROS quenching
To determine the role of ROS in ZnO nanoparticle-
induced cell death, U87 cells were seeded in a 
12-well plate at 1 mL per well at a concentration 
of 2 × 105 cells/mL. A stock solution of N-acetyl 
cysteine (NAC, Sigma Aldrich) was prepared in PBS 
and added to cells at 10 mmol/L for 1 h. After NAC 
pretreatment, cells were cultured with 10 mmol/L 
ZnO nanoparticles for 24 h. 
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